U.S., Nov. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07241741) titled 'The Predictive Role of Preoperative Pentraxin-3 (PTX3) in Metabolic and Inflammatory Outcomes After Roux-en-Y Gastric Bypass' on Sept. 03.
Brief Summary: This study evaluated the prognostic value of preoperative pentraxin-3 (PTX3) levels in predicting weight loss, inflammatory resolution (CRP, IL-6), and metabolic improvements (HOMA-IR) following Roux-en-Y gastric bypass in patients with obesity.
Study Start Date: Jan. 01, 2015
Study Type: OBSERVATIONAL
Condition:
Obesity
Metabolic Syndrome
Insulin Resistance
Inflammation
Roux en Y Gastric Bypass
Chronic Inflammation
C-Reactive Protein
Interleukin-6
Intervention:
OTHER: Biomar...